Cotización Medimmune - MEDI

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Último Precio

Postura de Compra

Postura de Venta

Volume Operado de la Acción

0.00 Rango del Día 0.00

0.00 Rango de 52 semanas 0.00

Precio Anterior

Precio de Apertura

Hora

Última hora de negociación

Volumen promedio (3 m)

Volumen financiero

Precio Promedio Ponderado

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

GAITHERSBURG, Md., June 18 /PRNewswire-FirstCall/ -- MedImmune, Inc. today announced that, in connection with the closing of the acquisition of MedImmune by AstraZeneca PLC pursuant to a...

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

Biotechnology Company Honored for Internal Launch of Productivity Tracking System GAITHERSBURG, Md., June 12 /PRNewswire-FirstCall/ -- MedImmune, Inc. today announced that the company was...

MedImmune Receives Correspondence From FDA Regarding FluMist(R)

GAITHERSBURG, Md., May 25 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) announced today that the U.S. Food and Drug Administration (FDA) has stated the agency has completed its review...

Anti-Interleukin-9 Data Presented at the American Thoracic Society Meeting

PLYMOUTH MEETING, Penn., May 24 /PRNewswire-FirstCall/ -- Genaera Corporation (NASDAQ:GENR) today reported that MedImmune, Inc. (NASDAQ:MEDI) presented data related to the Interleukin-9 (IL-9...

FDA Advisory Committee Recommends Expanded Use of FluMist(R)

GAITHERSBURG, Md., May 16 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) today announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products...

Data Show FluMist(R) May Reduce Seasonal Influenza Burden Among Children in School, Daycare Settings

New Economic Analyses of School and Daycare Study Outcomes Suggest Vaccinating Against Influenza May Produce Cost Savings for Community at Large TORONTO, May 8 /PRNewswire-FirstCall/...

MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Di

- Numax Achieves Primary Endpoint Among High-Risk Infants Versus Current Standard of Care and Shows Reduction of Medically Attended Outpatient RSV- Related Lower Respiratory Infections - TORONTO...

MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers

- Archana Singh, M.D., Winthrop University Hospital, Receives $35,000 Grant - TORONTO, May 7 /PRNewswire-FirstCall/ -- Underscoring its commitment to pediatric medicine, MedImmune, Inc...

MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers

- Victoria McMeen, M.D., University of Virginia, Receives $35,000 Grant - TORONTO, May 7 /PRNewswire-FirstCall/ -- Underscoring its commitment to pediatric medicine, MedImmune, Inc...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
ZENAZenaTech Inc	US$ 6.42 (258.66%)	116.26M
QMCOQuantum Corporation	US$ 21.67 (137.35%)	30.53M
SMTKSmartKem Inc	US$ 5.50 (71.88%)	3.13M
INVZWInnoviz Technologies Ltd	US$ 0.085 (70.00%)	152.17k
RGTIRigetti Computing Inc	US$ 2.75 (58.05%)	267.78M
SAVACassava Sciences Inc	US$ 4.295 (-83.78%)	92.51M
ONCTOncternal Therapeutics Inc	US$ 0.73 (-35.96%)	775.67k
CRKNCrown Electrokinetics Corporation	US$ 0.4246 (-35.43%)	12.69M
HTLMHomesToLife Ltd	US$ 2.60 (-34.59%)	213.36k
AMPGAmplitech Group Inc	US$ 0.92 (-25.81%)	688.86k
NVDANVIDIA Corporation	US$ 136.02 (-4.18%)	340.12M
ELABElevai Labs Inc	US$ 0.0157 (-21.89%)	323.5M
RGTIRigetti Computing Inc	US$ 2.75 (58.05%)	270.55M
SMCISuper Micro Computer Inc	US$ 38.42 (15.90%)	168.62M
CTXRCitius Pharmaceuticals Inc	US$ 0.1337 (-0.07%)	143.5M